nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—Fenofibrate—coronary artery disease	0.228	1	CrCtD
Indomethacin—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.192	1	CiPCiCtD
Indomethacin—Bezafibrate—Fenofibrate—coronary artery disease	0.086	1	CrCrCtD
Indomethacin—PLA2G2A—coronary artery disease	0.0662	0.554	CbGaD
Indomethacin—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.0475	0.413	CpDpCtD
Indomethacin—migraine—Acetylsalicylic acid—coronary artery disease	0.0344	0.298	CpDpCtD
Indomethacin—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.0333	0.289	CpDpCtD
Indomethacin—PPARA—Fenofibrate—coronary artery disease	0.0212	0.121	CbGbCtD
Indomethacin—CXCL8—coronary artery disease	0.0197	0.164	CbGaD
Indomethacin—PPARA—Gemfibrozil—coronary artery disease	0.017	0.0968	CbGbCtD
Indomethacin—PPARG—coronary artery disease	0.0136	0.114	CbGaD
Indomethacin—CYP2C19—coronary artery disease	0.00921	0.077	CbGaD
Indomethacin—CES1—Trandolapril—coronary artery disease	0.00668	0.0381	CbGbCtD
Indomethacin—SLC10A1—Pitavastatin—coronary artery disease	0.00639	0.0364	CbGbCtD
Indomethacin—CES1—Clopidogrel—coronary artery disease	0.00611	0.0348	CbGbCtD
Indomethacin—PTGS2—coronary artery disease	0.00574	0.048	CbGaD
Indomethacin—PPARG—Telmisartan—coronary artery disease	0.00534	0.0305	CbGbCtD
Indomethacin—ALB—coronary artery disease	0.00511	0.0427	CbGaD
Indomethacin—UGT2B7—Pitavastatin—coronary artery disease	0.00307	0.0175	CbGbCtD
Indomethacin—SLC22A7—Enalapril—coronary artery disease	0.00263	0.015	CbGbCtD
Indomethacin—ABCC3—Ezetimibe—coronary artery disease	0.00262	0.0149	CbGbCtD
Indomethacin—SLCO1B1—Gemfibrozil—coronary artery disease	0.00242	0.0138	CbGbCtD
Indomethacin—SLCO1B1—Olmesartan—coronary artery disease	0.0023	0.0131	CbGbCtD
Indomethacin—UGT2B7—Ezetimibe—coronary artery disease	0.00226	0.0129	CbGbCtD
Indomethacin—UGT2B7—Simvastatin—coronary artery disease	0.0021	0.012	CbGbCtD
Indomethacin—UGT2B7—Lovastatin—coronary artery disease	0.00206	0.0117	CbGbCtD
Indomethacin—ABCC2—Olmesartan—coronary artery disease	0.00202	0.0115	CbGbCtD
Indomethacin—ABCC4—Rosuvastatin—coronary artery disease	0.002	0.0114	CbGbCtD
Indomethacin—SLC22A7—Acetylsalicylic acid—coronary artery disease	0.002	0.0114	CbGbCtD
Indomethacin—UGT1A1—Ezetimibe—coronary artery disease	0.00196	0.0111	CbGbCtD
Indomethacin—SLC22A11—Pravastatin—coronary artery disease	0.00196	0.0111	CbGbCtD
Indomethacin—UGT2B7—Atorvastatin—coronary artery disease	0.00188	0.0107	CbGbCtD
Indomethacin—SLC22A7—Pravastatin—coronary artery disease	0.00186	0.0106	CbGbCtD
Indomethacin—SLCO1A2—Enalapril—coronary artery disease	0.00185	0.0105	CbGbCtD
Indomethacin—SLCO1B1—Pitavastatin—coronary artery disease	0.00184	0.0105	CbGbCtD
Indomethacin—UGT1A1—Simvastatin—coronary artery disease	0.00182	0.0104	CbGbCtD
Indomethacin—SLCO1B1—Valsartan—coronary artery disease	0.00179	0.0102	CbGbCtD
Indomethacin—UGT1A1—Lovastatin—coronary artery disease	0.00178	0.0101	CbGbCtD
Indomethacin—UGT2B7—Losartan—coronary artery disease	0.00171	0.00977	CbGbCtD
Indomethacin—SLC22A11—Furosemide—coronary artery disease	0.00166	0.00947	CbGbCtD
Indomethacin—ABCC4—Atorvastatin—coronary artery disease	0.00166	0.00944	CbGbCtD
Indomethacin—UGT1A1—Atorvastatin—coronary artery disease	0.00162	0.00923	CbGbCtD
Indomethacin—ABCC2—Pitavastatin—coronary artery disease	0.00161	0.0092	CbGbCtD
Indomethacin—ABCC2—Telmisartan—coronary artery disease	0.00161	0.0092	CbGbCtD
Indomethacin—ABCC1—Rosuvastatin—coronary artery disease	0.00161	0.00916	CbGbCtD
Indomethacin—SLC22A8—Enalapril—coronary artery disease	0.00161	0.00916	CbGbCtD
Indomethacin—UGT1A1—Losartan—coronary artery disease	0.00148	0.00845	CbGbCtD
Indomethacin—SLCO1A2—Rosuvastatin—coronary artery disease	0.00144	0.00818	CbGbCtD
Indomethacin—SLCO1B1—Ezetimibe—coronary artery disease	0.00135	0.00772	CbGbCtD
Indomethacin—SLCO1B1—Rosuvastatin—coronary artery disease	0.00135	0.00772	CbGbCtD
Indomethacin—SLCO1A2—Simvastatin—coronary artery disease	0.00133	0.0076	CbGbCtD
Indomethacin—ABCC1—Atorvastatin—coronary artery disease	0.00133	0.00759	CbGbCtD
Indomethacin—SLCO1A2—Pravastatin—coronary artery disease	0.00131	0.00744	CbGbCtD
Indomethacin—SLCO1A2—Lovastatin—coronary artery disease	0.00131	0.00744	CbGbCtD
Indomethacin—SLCO1B1—Simvastatin—coronary artery disease	0.00126	0.00717	CbGbCtD
Indomethacin—SLCO1B1—Lovastatin—coronary artery disease	0.00123	0.00702	CbGbCtD
Indomethacin—SLCO1B1—Pravastatin—coronary artery disease	0.00123	0.00702	CbGbCtD
Indomethacin—ABCC2—Ezetimibe—coronary artery disease	0.00119	0.00678	CbGbCtD
Indomethacin—SLCO1A2—Atorvastatin—coronary artery disease	0.00119	0.00678	CbGbCtD
Indomethacin—PTGS2—Acetylsalicylic acid—coronary artery disease	0.00115	0.00653	CbGbCtD
Indomethacin—SLC22A8—Pravastatin—coronary artery disease	0.00114	0.00648	CbGbCtD
Indomethacin—SLCO1B1—Atorvastatin—coronary artery disease	0.00112	0.00639	CbGbCtD
Indomethacin—SLC22A6—Enalapril—coronary artery disease	0.00112	0.00638	CbGbCtD
Indomethacin—ABCC2—Simvastatin—coronary artery disease	0.00111	0.0063	CbGbCtD
Indomethacin—ABCC2—Lovastatin—coronary artery disease	0.00108	0.00617	CbGbCtD
Indomethacin—ABCC2—Pravastatin—coronary artery disease	0.00108	0.00617	CbGbCtD
Indomethacin—SLCO1B1—Losartan—coronary artery disease	0.00103	0.00585	CbGbCtD
Indomethacin—ALB—Pitavastatin—coronary artery disease	0.00101	0.00573	CbGbCtD
Indomethacin—ABCC2—Atorvastatin—coronary artery disease	0.000986	0.00562	CbGbCtD
Indomethacin—ALB—Valsartan—coronary artery disease	0.000978	0.00558	CbGbCtD
Indomethacin—ABCB1—Ticagrelor—coronary artery disease	0.000974	0.00555	CbGbCtD
Indomethacin—PTGS1—Acetylsalicylic acid—coronary artery disease	0.000968	0.00551	CbGbCtD
Indomethacin—SLC22A8—Furosemide—coronary artery disease	0.000967	0.00551	CbGbCtD
Indomethacin—ABCC2—Furosemide—coronary artery disease	0.00092	0.00524	CbGbCtD
Indomethacin—CYP2C9—Fenofibrate—coronary artery disease	0.000895	0.0051	CbGbCtD
Indomethacin—CYP2C9—cardial valve—coronary artery disease	0.000876	0.0847	CbGeAlD
Indomethacin—CYP2C19—Gemfibrozil—coronary artery disease	0.00086	0.0049	CbGbCtD
Indomethacin—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.000848	0.00483	CbGbCtD
Indomethacin—SLC22A6—Captopril—coronary artery disease	0.000838	0.00478	CbGbCtD
Indomethacin—SLC22A6—Pravastatin—coronary artery disease	0.000792	0.00451	CbGbCtD
Indomethacin—CYP2C19—Clopidogrel—coronary artery disease	0.000746	0.00425	CbGbCtD
Indomethacin—ALB—Rosuvastatin—coronary artery disease	0.000742	0.00423	CbGbCtD
Indomethacin—ALB—Acetylsalicylic acid—coronary artery disease	0.000723	0.00412	CbGbCtD
Indomethacin—CYP2C9—Gemfibrozil—coronary artery disease	0.000715	0.00408	CbGbCtD
Indomethacin—ALB—Captopril—coronary artery disease	0.000714	0.00407	CbGbCtD
Indomethacin—SLC22A6—Furosemide—coronary artery disease	0.000674	0.00384	CbGbCtD
Indomethacin—SLC22A6—Losartan—coronary artery disease	0.00066	0.00376	CbGbCtD
Indomethacin—CYP2C19—Telmisartan—coronary artery disease	0.000652	0.00372	CbGbCtD
Indomethacin—CYP2C9—Clopidogrel—coronary artery disease	0.00062	0.00353	CbGbCtD
Indomethacin—ABCB1—Perindopril—coronary artery disease	0.000602	0.00343	CbGbCtD
Indomethacin—ABCB1—Clopidogrel—coronary artery disease	0.000602	0.00343	CbGbCtD
Indomethacin—ALB—Furosemide—coronary artery disease	0.000574	0.00327	CbGbCtD
Indomethacin—ALB—Losartan—coronary artery disease	0.000562	0.0032	CbGbCtD
Indomethacin—CYP2C9—Pitavastatin—coronary artery disease	0.000542	0.00309	CbGbCtD
Indomethacin—CYP2C9—Valsartan—coronary artery disease	0.000527	0.00301	CbGbCtD
Indomethacin—ABCB1—Pitavastatin—coronary artery disease	0.000526	0.003	CbGbCtD
Indomethacin—ABCB1—Telmisartan—coronary artery disease	0.000526	0.003	CbGbCtD
Indomethacin—CYP2C19—Timolol—coronary artery disease	0.000526	0.00299	CbGbCtD
Indomethacin—ABCB1—Lisinopril—coronary artery disease	0.000499	0.00284	CbGbCtD
Indomethacin—ABCB1—Enalapril—coronary artery disease	0.000499	0.00284	CbGbCtD
Indomethacin—CYP2C19—Rosuvastatin—coronary artery disease	0.000481	0.00274	CbGbCtD
Indomethacin—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.000468	0.00267	CbGbCtD
Indomethacin—CYP2C19—Simvastatin—coronary artery disease	0.000447	0.00255	CbGbCtD
Indomethacin—CYP2C19—Lovastatin—coronary artery disease	0.000437	0.00249	CbGbCtD
Indomethacin—PTGR2—cardiac ventricle—coronary artery disease	0.000427	0.0413	CbGeAlD
Indomethacin—ABCB1—Timolol—coronary artery disease	0.000424	0.00242	CbGbCtD
Indomethacin—PTGDR2—heart—coronary artery disease	0.000422	0.0408	CbGeAlD
Indomethacin—PTGR2—myocardium—coronary artery disease	0.000401	0.0388	CbGeAlD
Indomethacin—CYP2C9—Rosuvastatin—coronary artery disease	0.0004	0.00228	CbGbCtD
Indomethacin—CYP2C19—Atorvastatin—coronary artery disease	0.000398	0.00227	CbGbCtD
Indomethacin—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.000389	0.00222	CbGbCtD
Indomethacin—ABCB1—Ezetimibe—coronary artery disease	0.000388	0.00221	CbGbCtD
Indomethacin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.000378	0.00215	CbGbCtD
Indomethacin—ABCB1—Captopril—coronary artery disease	0.000373	0.00213	CbGbCtD
Indomethacin—CYP2C9—Simvastatin—coronary artery disease	0.000372	0.00212	CbGbCtD
Indomethacin—CYP2C19—Losartan—coronary artery disease	0.000364	0.00208	CbGbCtD
Indomethacin—CYP2C9—Lovastatin—coronary artery disease	0.000364	0.00207	CbGbCtD
Indomethacin—CYP2C9—Pravastatin—coronary artery disease	0.000364	0.00207	CbGbCtD
Indomethacin—ABCB1—Simvastatin—coronary artery disease	0.000361	0.00205	CbGbCtD
Indomethacin—ABCB1—Pravastatin—coronary artery disease	0.000353	0.00201	CbGbCtD
Indomethacin—ABCB1—Lovastatin—coronary artery disease	0.000353	0.00201	CbGbCtD
Indomethacin—CYP2C9—Atorvastatin—coronary artery disease	0.000331	0.00189	CbGbCtD
Indomethacin—ABCB1—Atorvastatin—coronary artery disease	0.000321	0.00183	CbGbCtD
Indomethacin—PTGDR2—blood—coronary artery disease	0.000315	0.0305	CbGeAlD
Indomethacin—CYP2C9—Losartan—coronary artery disease	0.000303	0.00173	CbGbCtD
Indomethacin—ABCB1—Losartan—coronary artery disease	0.000294	0.00168	CbGbCtD
Indomethacin—PTGR2—heart—coronary artery disease	0.00028	0.0271	CbGeAlD
Indomethacin—PTGR2—cardiovascular system—coronary artery disease	0.000264	0.0256	CbGeAlD
Indomethacin—GLO1—cardiac ventricle—coronary artery disease	0.000264	0.0255	CbGeAlD
Indomethacin—GLO1—myocardium—coronary artery disease	0.000248	0.024	CbGeAlD
Indomethacin—PLA2G2A—cardiac ventricle—coronary artery disease	0.000245	0.0237	CbGeAlD
Indomethacin—PTGR2—cardiac atrium—coronary artery disease	0.00024	0.0232	CbGeAlD
Indomethacin—PLA2G2A—myocardium—coronary artery disease	0.000231	0.0223	CbGeAlD
Indomethacin—PPARG—artery—coronary artery disease	0.000224	0.0217	CbGeAlD
Indomethacin—PPARA—myocardium—coronary artery disease	0.000215	0.0208	CbGeAlD
Indomethacin—PTGR2—blood—coronary artery disease	0.000209	0.0202	CbGeAlD
Indomethacin—AKR1C3—cardiac ventricle—coronary artery disease	0.00019	0.0184	CbGeAlD
Indomethacin—PPARG—endothelium—coronary artery disease	0.00019	0.0183	CbGeAlD
Indomethacin—AKR1C3—myocardium—coronary artery disease	0.000179	0.0173	CbGeAlD
Indomethacin—GLO1—heart—coronary artery disease	0.000173	0.0167	CbGeAlD
Indomethacin—GLO1—cardiovascular system—coronary artery disease	0.000163	0.0158	CbGeAlD
Indomethacin—PLA2G2A—heart—coronary artery disease	0.000161	0.0156	CbGeAlD
Indomethacin—CXCL8—heart—coronary artery disease	0.000159	0.0154	CbGeAlD
Indomethacin—Bezafibrate—HMGCR—coronary artery disease	0.000156	0.257	CrCbGaD
Indomethacin—PLA2G2A—cardiovascular system—coronary artery disease	0.000152	0.0147	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—coronary artery disease	0.00015	0.0145	CbGeAlD
Indomethacin—PPARA—heart—coronary artery disease	0.00015	0.0145	CbGeAlD
Indomethacin—GLO1—cardiac atrium—coronary artery disease	0.000148	0.0143	CbGeAlD
Indomethacin—PPARA—cardiovascular system—coronary artery disease	0.000142	0.0137	CbGeAlD
Indomethacin—PLA2G2A—cardiac atrium—coronary artery disease	0.000138	0.0133	CbGeAlD
Indomethacin—Tolmetin—CXCL8—coronary artery disease	0.00013	0.213	CrCbGaD
Indomethacin—GLO1—blood—coronary artery disease	0.000129	0.0125	CbGeAlD
Indomethacin—AKR1C3—heart—coronary artery disease	0.000125	0.0121	CbGeAlD
Indomethacin—PLA2G2A—blood—coronary artery disease	0.00012	0.0116	CbGeAlD
Indomethacin—PTGS1—artery—coronary artery disease	0.00012	0.0116	CbGeAlD
Indomethacin—ABCC6—blood—coronary artery disease	0.000119	0.0115	CbGeAlD
Indomethacin—CXCL8—blood—coronary artery disease	0.000119	0.0115	CbGeAlD
Indomethacin—PPARG—myocardium—coronary artery disease	0.000118	0.0115	CbGeAlD
Indomethacin—PTGS2—artery—coronary artery disease	0.000115	0.0111	CbGeAlD
Indomethacin—PPARA—blood—coronary artery disease	0.000112	0.0109	CbGeAlD
Indomethacin—CES1—heart—coronary artery disease	0.000112	0.0108	CbGeAlD
Indomethacin—AKR1C3—cardiac atrium—coronary artery disease	0.000107	0.0103	CbGeAlD
Indomethacin—CES1—cardiovascular system—coronary artery disease	0.000105	0.0102	CbGeAlD
Indomethacin—PTGS1—endothelium—coronary artery disease	0.000101	0.0098	CbGeAlD
Indomethacin—Tolmetin—MPO—coronary artery disease	0.000101	0.166	CrCbGaD
Indomethacin—PTGS2—endothelium—coronary artery disease	9.69e-05	0.00937	CbGeAlD
Indomethacin—AKR1C3—blood—coronary artery disease	9.32e-05	0.00902	CbGeAlD
Indomethacin—ABCC1—myocardium—coronary artery disease	9.17e-05	0.00887	CbGeAlD
Indomethacin—UGT1A1—blood—coronary artery disease	8.59e-05	0.00831	CbGeAlD
Indomethacin—CES1—blood—coronary artery disease	8.32e-05	0.00805	CbGeAlD
Indomethacin—PPARG—heart—coronary artery disease	8.27e-05	0.008	CbGeAlD
Indomethacin—PPARG—cardiovascular system—coronary artery disease	7.8e-05	0.00754	CbGeAlD
Indomethacin—ALB—heart—coronary artery disease	7.75e-05	0.0075	CbGeAlD
Indomethacin—ABCC4—heart—coronary artery disease	7.51e-05	0.00726	CbGeAlD
Indomethacin—Bezafibrate—PPARG—coronary artery disease	7.37e-05	0.121	CrCbGaD
Indomethacin—SLCO1B1—blood—coronary artery disease	7.15e-05	0.00692	CbGeAlD
Indomethacin—ABCC3—blood—coronary artery disease	6.79e-05	0.00656	CbGeAlD
Indomethacin—ABCC1—heart—coronary artery disease	6.4e-05	0.00619	CbGeAlD
Indomethacin—PTGS1—myocardium—coronary artery disease	6.33e-05	0.00612	CbGeAlD
Indomethacin—PPARG—blood—coronary artery disease	6.17e-05	0.00597	CbGeAlD
Indomethacin—Bromfenac—PTGS2—coronary artery disease	5.63e-05	0.0925	CrCbGaD
Indomethacin—ABCC4—blood—coronary artery disease	5.6e-05	0.00542	CbGeAlD
Indomethacin—SLC22A8—blood—coronary artery disease	5.56e-05	0.00538	CbGeAlD
Indomethacin—ABCC1—cardiac atrium—coronary artery disease	5.47e-05	0.00529	CbGeAlD
Indomethacin—ABCC2—blood—coronary artery disease	5.42e-05	0.00524	CbGeAlD
Indomethacin—CYP2C9—heart—coronary artery disease	4.84e-05	0.00468	CbGeAlD
Indomethacin—ABCC1—blood—coronary artery disease	4.78e-05	0.00462	CbGeAlD
Indomethacin—CYP2C19—blood—coronary artery disease	4.66e-05	0.00451	CbGeAlD
Indomethacin—CYP2C9—cardiovascular system—coronary artery disease	4.57e-05	0.00442	CbGeAlD
Indomethacin—PTGS1—heart—coronary artery disease	4.42e-05	0.00427	CbGeAlD
Indomethacin—PTGS2—heart—coronary artery disease	4.22e-05	0.00409	CbGeAlD
Indomethacin—PTGS1—cardiovascular system—coronary artery disease	4.17e-05	0.00403	CbGeAlD
Indomethacin—PTGS2—cardiovascular system—coronary artery disease	3.99e-05	0.00386	CbGeAlD
Indomethacin—Tolmetin—PTGS2—coronary artery disease	3.78e-05	0.0622	CrCbGaD
Indomethacin—PTGS1—cardiac atrium—coronary artery disease	3.78e-05	0.00366	CbGeAlD
Indomethacin—CYP2C9—blood—coronary artery disease	3.61e-05	0.00349	CbGeAlD
Indomethacin—PTGS1—blood—coronary artery disease	3.3e-05	0.00319	CbGeAlD
Indomethacin—PTGS2—blood—coronary artery disease	3.15e-05	0.00305	CbGeAlD
Indomethacin—Naproxen—PTGS2—coronary artery disease	2.85e-05	0.0468	CrCbGaD
Indomethacin—ABCB1—heart—coronary artery disease	2.61e-05	0.00253	CbGeAlD
Indomethacin—Naproxen—ALB—coronary artery disease	2.54e-05	0.0417	CrCbGaD
Indomethacin—ABCB1—cardiovascular system—coronary artery disease	2.47e-05	0.00238	CbGeAlD
Indomethacin—ABCB1—blood—coronary artery disease	1.95e-05	0.00189	CbGeAlD
Indomethacin—Pruritus—Valsartan—coronary artery disease	1.11e-05	0.000272	CcSEcCtD
Indomethacin—Chest pain—Timolol—coronary artery disease	1.11e-05	0.000272	CcSEcCtD
Indomethacin—Vomiting—Ezetimibe—coronary artery disease	1.11e-05	0.000271	CcSEcCtD
Indomethacin—Hypersensitivity—Pravastatin—coronary artery disease	1.11e-05	0.000271	CcSEcCtD
Indomethacin—Gastrointestinal pain—Perindopril—coronary artery disease	1.11e-05	0.000271	CcSEcCtD
Indomethacin—Anxiety—Timolol—coronary artery disease	1.1e-05	0.000271	CcSEcCtD
Indomethacin—Angioedema—Lisinopril—coronary artery disease	1.1e-05	0.000271	CcSEcCtD
Indomethacin—Pruritus—Olmesartan—coronary artery disease	1.1e-05	0.000271	CcSEcCtD
Indomethacin—Decreased appetite—Losartan—coronary artery disease	1.1e-05	0.00027	CcSEcCtD
Indomethacin—Abdominal pain—Captopril—coronary artery disease	1.1e-05	0.00027	CcSEcCtD
Indomethacin—Body temperature increased—Captopril—coronary artery disease	1.1e-05	0.00027	CcSEcCtD
Indomethacin—Dizziness—Simvastatin—coronary artery disease	1.1e-05	0.000269	CcSEcCtD
Indomethacin—Rash—Ezetimibe—coronary artery disease	1.1e-05	0.000269	CcSEcCtD
Indomethacin—Dermatitis—Ezetimibe—coronary artery disease	1.1e-05	0.000269	CcSEcCtD
Indomethacin—Confusional state—Ramipril—coronary artery disease	1.1e-05	0.000269	CcSEcCtD
Indomethacin—Discomfort—Timolol—coronary artery disease	1.1e-05	0.000269	CcSEcCtD
Indomethacin—Asthenia—Niacin—coronary artery disease	1.09e-05	0.000268	CcSEcCtD
Indomethacin—Fatigue—Losartan—coronary artery disease	1.09e-05	0.000268	CcSEcCtD
Indomethacin—Headache—Ezetimibe—coronary artery disease	1.09e-05	0.000267	CcSEcCtD
Indomethacin—Malaise—Lisinopril—coronary artery disease	1.09e-05	0.000267	CcSEcCtD
Indomethacin—Oedema—Ramipril—coronary artery disease	1.09e-05	0.000267	CcSEcCtD
Indomethacin—Anaphylactic shock—Ramipril—coronary artery disease	1.09e-05	0.000267	CcSEcCtD
Indomethacin—Vertigo—Lisinopril—coronary artery disease	1.09e-05	0.000266	CcSEcCtD
Indomethacin—Constipation—Losartan—coronary artery disease	1.08e-05	0.000266	CcSEcCtD
Indomethacin—Pain—Losartan—coronary artery disease	1.08e-05	0.000266	CcSEcCtD
Indomethacin—Syncope—Lisinopril—coronary artery disease	1.08e-05	0.000266	CcSEcCtD
Indomethacin—Vomiting—Eplerenone—coronary artery disease	1.08e-05	0.000266	CcSEcCtD
Indomethacin—Feeling abnormal—Furosemide—coronary artery disease	1.08e-05	0.000266	CcSEcCtD
Indomethacin—Leukopenia—Lisinopril—coronary artery disease	1.08e-05	0.000265	CcSEcCtD
Indomethacin—Nausea—Fenofibrate—coronary artery disease	1.08e-05	0.000265	CcSEcCtD
Indomethacin—Pruritus—Niacin—coronary artery disease	1.08e-05	0.000265	CcSEcCtD
Indomethacin—Asthenia—Pravastatin—coronary artery disease	1.08e-05	0.000264	CcSEcCtD
Indomethacin—Gastrointestinal pain—Furosemide—coronary artery disease	1.07e-05	0.000264	CcSEcCtD
Indomethacin—Rash—Eplerenone—coronary artery disease	1.07e-05	0.000264	CcSEcCtD
Indomethacin—Urticaria—Perindopril—coronary artery disease	1.07e-05	0.000263	CcSEcCtD
Indomethacin—Hypersensitivity—Trandolapril—coronary artery disease	1.07e-05	0.000263	CcSEcCtD
Indomethacin—Dermatitis—Eplerenone—coronary artery disease	1.07e-05	0.000263	CcSEcCtD
Indomethacin—Diarrhoea—Valsartan—coronary artery disease	1.07e-05	0.000263	CcSEcCtD
Indomethacin—Confusional state—Timolol—coronary artery disease	1.07e-05	0.000263	CcSEcCtD
Indomethacin—Shock—Ramipril—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Hypersensitivity—Enalapril—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Abdominal pain—Perindopril—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Body temperature increased—Perindopril—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Palpitations—Lisinopril—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Diarrhoea—Olmesartan—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Headache—Eplerenone—coronary artery disease	1.07e-05	0.000262	CcSEcCtD
Indomethacin—Thrombocytopenia—Ramipril—coronary artery disease	1.06e-05	0.000261	CcSEcCtD
Indomethacin—Anaphylactic shock—Timolol—coronary artery disease	1.06e-05	0.000261	CcSEcCtD
Indomethacin—Oedema—Timolol—coronary artery disease	1.06e-05	0.000261	CcSEcCtD
Indomethacin—Pruritus—Pravastatin—coronary artery disease	1.06e-05	0.00026	CcSEcCtD
Indomethacin—Loss of consciousness—Lisinopril—coronary artery disease	1.06e-05	0.00026	CcSEcCtD
Indomethacin—Nausea—Clopidogrel—coronary artery disease	1.06e-05	0.00026	CcSEcCtD
Indomethacin—Tachycardia—Ramipril—coronary artery disease	1.06e-05	0.00026	CcSEcCtD
Indomethacin—Vomiting—Simvastatin—coronary artery disease	1.06e-05	0.000259	CcSEcCtD
Indomethacin—Hypersensitivity—Telmisartan—coronary artery disease	1.05e-05	0.000259	CcSEcCtD
Indomethacin—Nausea—Lovastatin—coronary artery disease	1.05e-05	0.000259	CcSEcCtD
Indomethacin—Hyperhidrosis—Ramipril—coronary artery disease	1.05e-05	0.000258	CcSEcCtD
Indomethacin—Rash—Simvastatin—coronary artery disease	1.05e-05	0.000257	CcSEcCtD
Indomethacin—Dermatitis—Simvastatin—coronary artery disease	1.05e-05	0.000257	CcSEcCtD
Indomethacin—Asthenia—Trandolapril—coronary artery disease	1.05e-05	0.000256	CcSEcCtD
Indomethacin—Shock—Timolol—coronary artery disease	1.05e-05	0.000256	CcSEcCtD
Indomethacin—Feeling abnormal—Losartan—coronary artery disease	1.04e-05	0.000256	CcSEcCtD
Indomethacin—Urticaria—Furosemide—coronary artery disease	1.04e-05	0.000256	CcSEcCtD
Indomethacin—Diarrhoea—Niacin—coronary artery disease	1.04e-05	0.000256	CcSEcCtD
Indomethacin—Asthenia—Enalapril—coronary artery disease	1.04e-05	0.000255	CcSEcCtD
Indomethacin—Headache—Simvastatin—coronary artery disease	1.04e-05	0.000255	CcSEcCtD
Indomethacin—Abdominal pain—Furosemide—coronary artery disease	1.04e-05	0.000255	CcSEcCtD
Indomethacin—Body temperature increased—Furosemide—coronary artery disease	1.04e-05	0.000255	CcSEcCtD
Indomethacin—Gastrointestinal pain—Losartan—coronary artery disease	1.04e-05	0.000254	CcSEcCtD
Indomethacin—Dizziness—Valsartan—coronary artery disease	1.04e-05	0.000254	CcSEcCtD
Indomethacin—Anorexia—Ramipril—coronary artery disease	1.04e-05	0.000254	CcSEcCtD
Indomethacin—Nausea—Ezetimibe—coronary artery disease	1.03e-05	0.000254	CcSEcCtD
Indomethacin—Dizziness—Olmesartan—coronary artery disease	1.03e-05	0.000253	CcSEcCtD
Indomethacin—Pruritus—Trandolapril—coronary artery disease	1.03e-05	0.000253	CcSEcCtD
Indomethacin—Chest pain—Lisinopril—coronary artery disease	1.03e-05	0.000252	CcSEcCtD
Indomethacin—Hyperhidrosis—Timolol—coronary artery disease	1.03e-05	0.000252	CcSEcCtD
Indomethacin—Asthenia—Telmisartan—coronary artery disease	1.03e-05	0.000252	CcSEcCtD
Indomethacin—Pruritus—Enalapril—coronary artery disease	1.03e-05	0.000252	CcSEcCtD
Indomethacin—Diarrhoea—Pravastatin—coronary artery disease	1.03e-05	0.000252	CcSEcCtD
Indomethacin—Anxiety—Lisinopril—coronary artery disease	1.02e-05	0.000251	CcSEcCtD
Indomethacin—Discomfort—Lisinopril—coronary artery disease	1.02e-05	0.000249	CcSEcCtD
Indomethacin—Hypotension—Ramipril—coronary artery disease	1.02e-05	0.000249	CcSEcCtD
Indomethacin—Anorexia—Timolol—coronary artery disease	1.01e-05	0.000249	CcSEcCtD
Indomethacin—Pruritus—Telmisartan—coronary artery disease	1.01e-05	0.000248	CcSEcCtD
Indomethacin—Nausea—Eplerenone—coronary artery disease	1.01e-05	0.000248	CcSEcCtD
Indomethacin—Dizziness—Niacin—coronary artery disease	1.01e-05	0.000247	CcSEcCtD
Indomethacin—Urticaria—Losartan—coronary artery disease	1.01e-05	0.000247	CcSEcCtD
Indomethacin—Abdominal pain—Losartan—coronary artery disease	1e-05	0.000246	CcSEcCtD
Indomethacin—Body temperature increased—Losartan—coronary artery disease	1e-05	0.000246	CcSEcCtD
Indomethacin—Asthenia—Captopril—coronary artery disease	9.99e-06	0.000245	CcSEcCtD
Indomethacin—Diarrhoea—Trandolapril—coronary artery disease	9.97e-06	0.000245	CcSEcCtD
Indomethacin—Vomiting—Valsartan—coronary artery disease	9.97e-06	0.000244	CcSEcCtD
Indomethacin—Confusional state—Lisinopril—coronary artery disease	9.94e-06	0.000244	CcSEcCtD
Indomethacin—Diarrhoea—Enalapril—coronary artery disease	9.93e-06	0.000244	CcSEcCtD
Indomethacin—Hypotension—Timolol—coronary artery disease	9.93e-06	0.000244	CcSEcCtD
Indomethacin—Dizziness—Pravastatin—coronary artery disease	9.92e-06	0.000243	CcSEcCtD
Indomethacin—Vomiting—Olmesartan—coronary artery disease	9.92e-06	0.000243	CcSEcCtD
Indomethacin—Rash—Valsartan—coronary artery disease	9.88e-06	0.000242	CcSEcCtD
Indomethacin—Dermatitis—Valsartan—coronary artery disease	9.87e-06	0.000242	CcSEcCtD
Indomethacin—Nausea—Simvastatin—coronary artery disease	9.86e-06	0.000242	CcSEcCtD
Indomethacin—Oedema—Lisinopril—coronary artery disease	9.86e-06	0.000242	CcSEcCtD
Indomethacin—Anaphylactic shock—Lisinopril—coronary artery disease	9.86e-06	0.000242	CcSEcCtD
Indomethacin—Pruritus—Captopril—coronary artery disease	9.85e-06	0.000242	CcSEcCtD
Indomethacin—Rash—Olmesartan—coronary artery disease	9.84e-06	0.000241	CcSEcCtD
Indomethacin—Insomnia—Ramipril—coronary artery disease	9.83e-06	0.000241	CcSEcCtD
Indomethacin—Dermatitis—Olmesartan—coronary artery disease	9.83e-06	0.000241	CcSEcCtD
Indomethacin—Headache—Valsartan—coronary artery disease	9.82e-06	0.000241	CcSEcCtD
Indomethacin—Diarrhoea—Telmisartan—coronary artery disease	9.8e-06	0.00024	CcSEcCtD
Indomethacin—Headache—Olmesartan—coronary artery disease	9.77e-06	0.00024	CcSEcCtD
Indomethacin—Paraesthesia—Ramipril—coronary artery disease	9.76e-06	0.000239	CcSEcCtD
Indomethacin—Shock—Lisinopril—coronary artery disease	9.7e-06	0.000238	CcSEcCtD
Indomethacin—Asthenia—Perindopril—coronary artery disease	9.7e-06	0.000238	CcSEcCtD
Indomethacin—Dyspnoea—Ramipril—coronary artery disease	9.69e-06	0.000238	CcSEcCtD
Indomethacin—Vomiting—Niacin—coronary artery disease	9.69e-06	0.000238	CcSEcCtD
Indomethacin—Hypersensitivity—Furosemide—coronary artery disease	9.68e-06	0.000237	CcSEcCtD
Indomethacin—Somnolence—Ramipril—coronary artery disease	9.66e-06	0.000237	CcSEcCtD
Indomethacin—Thrombocytopenia—Lisinopril—coronary artery disease	9.65e-06	0.000237	CcSEcCtD
Indomethacin—Dizziness—Trandolapril—coronary artery disease	9.64e-06	0.000236	CcSEcCtD
Indomethacin—Tachycardia—Lisinopril—coronary artery disease	9.62e-06	0.000236	CcSEcCtD
Indomethacin—Insomnia—Timolol—coronary artery disease	9.61e-06	0.000236	CcSEcCtD
Indomethacin—Rash—Niacin—coronary artery disease	9.61e-06	0.000236	CcSEcCtD
Indomethacin—Dermatitis—Niacin—coronary artery disease	9.6e-06	0.000236	CcSEcCtD
Indomethacin—Dizziness—Enalapril—coronary artery disease	9.6e-06	0.000235	CcSEcCtD
Indomethacin—Dyspepsia—Ramipril—coronary artery disease	9.57e-06	0.000235	CcSEcCtD
Indomethacin—Pruritus—Perindopril—coronary artery disease	9.56e-06	0.000235	CcSEcCtD
Indomethacin—Headache—Niacin—coronary artery disease	9.55e-06	0.000234	CcSEcCtD
Indomethacin—Paraesthesia—Timolol—coronary artery disease	9.54e-06	0.000234	CcSEcCtD
Indomethacin—Vomiting—Pravastatin—coronary artery disease	9.54e-06	0.000234	CcSEcCtD
Indomethacin—Hyperhidrosis—Lisinopril—coronary artery disease	9.53e-06	0.000234	CcSEcCtD
Indomethacin—Diarrhoea—Captopril—coronary artery disease	9.53e-06	0.000234	CcSEcCtD
Indomethacin—Dyspnoea—Timolol—coronary artery disease	9.47e-06	0.000232	CcSEcCtD
Indomethacin—Dizziness—Telmisartan—coronary artery disease	9.47e-06	0.000232	CcSEcCtD
Indomethacin—Rash—Pravastatin—coronary artery disease	9.46e-06	0.000232	CcSEcCtD
Indomethacin—Dermatitis—Pravastatin—coronary artery disease	9.45e-06	0.000232	CcSEcCtD
Indomethacin—Decreased appetite—Ramipril—coronary artery disease	9.45e-06	0.000232	CcSEcCtD
Indomethacin—Somnolence—Timolol—coronary artery disease	9.45e-06	0.000232	CcSEcCtD
Indomethacin—Asthenia—Furosemide—coronary artery disease	9.43e-06	0.000231	CcSEcCtD
Indomethacin—Headache—Pravastatin—coronary artery disease	9.4e-06	0.000231	CcSEcCtD
Indomethacin—Anorexia—Lisinopril—coronary artery disease	9.4e-06	0.000231	CcSEcCtD
Indomethacin—Fatigue—Ramipril—coronary artery disease	9.37e-06	0.00023	CcSEcCtD
Indomethacin—Dyspepsia—Timolol—coronary artery disease	9.36e-06	0.000229	CcSEcCtD
Indomethacin—Hypersensitivity—Losartan—coronary artery disease	9.34e-06	0.000229	CcSEcCtD
Indomethacin—Nausea—Valsartan—coronary artery disease	9.31e-06	0.000228	CcSEcCtD
Indomethacin—Pruritus—Furosemide—coronary artery disease	9.3e-06	0.000228	CcSEcCtD
Indomethacin—Constipation—Ramipril—coronary artery disease	9.3e-06	0.000228	CcSEcCtD
Indomethacin—Nausea—Olmesartan—coronary artery disease	9.27e-06	0.000227	CcSEcCtD
Indomethacin—Vomiting—Trandolapril—coronary artery disease	9.27e-06	0.000227	CcSEcCtD
Indomethacin—Diarrhoea—Perindopril—coronary artery disease	9.25e-06	0.000227	CcSEcCtD
Indomethacin—Decreased appetite—Timolol—coronary artery disease	9.24e-06	0.000227	CcSEcCtD
Indomethacin—Vomiting—Enalapril—coronary artery disease	9.23e-06	0.000226	CcSEcCtD
Indomethacin—Hypotension—Lisinopril—coronary artery disease	9.21e-06	0.000226	CcSEcCtD
Indomethacin—Dizziness—Captopril—coronary artery disease	9.21e-06	0.000226	CcSEcCtD
Indomethacin—Rash—Trandolapril—coronary artery disease	9.19e-06	0.000225	CcSEcCtD
Indomethacin—Dermatitis—Trandolapril—coronary artery disease	9.18e-06	0.000225	CcSEcCtD
Indomethacin—Fatigue—Timolol—coronary artery disease	9.16e-06	0.000225	CcSEcCtD
Indomethacin—Rash—Enalapril—coronary artery disease	9.15e-06	0.000225	CcSEcCtD
Indomethacin—Dermatitis—Enalapril—coronary artery disease	9.14e-06	0.000224	CcSEcCtD
Indomethacin—Headache—Trandolapril—coronary artery disease	9.13e-06	0.000224	CcSEcCtD
Indomethacin—Vomiting—Telmisartan—coronary artery disease	9.1e-06	0.000223	CcSEcCtD
Indomethacin—Asthenia—Losartan—coronary artery disease	9.1e-06	0.000223	CcSEcCtD
Indomethacin—Headache—Enalapril—coronary artery disease	9.09e-06	0.000223	CcSEcCtD
Indomethacin—Pain—Timolol—coronary artery disease	9.09e-06	0.000223	CcSEcCtD
Indomethacin—Nausea—Niacin—coronary artery disease	9.05e-06	0.000222	CcSEcCtD
Indomethacin—Rash—Telmisartan—coronary artery disease	9.03e-06	0.000221	CcSEcCtD
Indomethacin—Dermatitis—Telmisartan—coronary artery disease	9.02e-06	0.000221	CcSEcCtD
Indomethacin—Diarrhoea—Furosemide—coronary artery disease	8.99e-06	0.000221	CcSEcCtD
Indomethacin—Pruritus—Losartan—coronary artery disease	8.97e-06	0.00022	CcSEcCtD
Indomethacin—Headache—Telmisartan—coronary artery disease	8.97e-06	0.00022	CcSEcCtD
Indomethacin—Feeling abnormal—Ramipril—coronary artery disease	8.96e-06	0.00022	CcSEcCtD
Indomethacin—Dizziness—Perindopril—coronary artery disease	8.94e-06	0.000219	CcSEcCtD
Indomethacin—Insomnia—Lisinopril—coronary artery disease	8.92e-06	0.000219	CcSEcCtD
Indomethacin—Nausea—Pravastatin—coronary artery disease	8.91e-06	0.000219	CcSEcCtD
Indomethacin—Gastrointestinal pain—Ramipril—coronary artery disease	8.89e-06	0.000218	CcSEcCtD
Indomethacin—Paraesthesia—Lisinopril—coronary artery disease	8.85e-06	0.000217	CcSEcCtD
Indomethacin—Vomiting—Captopril—coronary artery disease	8.85e-06	0.000217	CcSEcCtD
Indomethacin—Dyspnoea—Lisinopril—coronary artery disease	8.79e-06	0.000216	CcSEcCtD
Indomethacin—Rash—Captopril—coronary artery disease	8.78e-06	0.000215	CcSEcCtD
Indomethacin—Dermatitis—Captopril—coronary artery disease	8.77e-06	0.000215	CcSEcCtD
Indomethacin—Somnolence—Lisinopril—coronary artery disease	8.76e-06	0.000215	CcSEcCtD
Indomethacin—Feeling abnormal—Timolol—coronary artery disease	8.76e-06	0.000215	CcSEcCtD
Indomethacin—Headache—Captopril—coronary artery disease	8.72e-06	0.000214	CcSEcCtD
Indomethacin—Gastrointestinal pain—Timolol—coronary artery disease	8.69e-06	0.000213	CcSEcCtD
Indomethacin—Dizziness—Furosemide—coronary artery disease	8.69e-06	0.000213	CcSEcCtD
Indomethacin—Dyspepsia—Lisinopril—coronary artery disease	8.68e-06	0.000213	CcSEcCtD
Indomethacin—Diarrhoea—Losartan—coronary artery disease	8.67e-06	0.000213	CcSEcCtD
Indomethacin—Nausea—Trandolapril—coronary artery disease	8.66e-06	0.000212	CcSEcCtD
Indomethacin—Urticaria—Ramipril—coronary artery disease	8.64e-06	0.000212	CcSEcCtD
Indomethacin—Nausea—Enalapril—coronary artery disease	8.62e-06	0.000211	CcSEcCtD
Indomethacin—Vomiting—Perindopril—coronary artery disease	8.59e-06	0.000211	CcSEcCtD
Indomethacin—Abdominal pain—Ramipril—coronary artery disease	8.59e-06	0.000211	CcSEcCtD
Indomethacin—Body temperature increased—Ramipril—coronary artery disease	8.59e-06	0.000211	CcSEcCtD
Indomethacin—Decreased appetite—Lisinopril—coronary artery disease	8.57e-06	0.00021	CcSEcCtD
Indomethacin—Rash—Perindopril—coronary artery disease	8.52e-06	0.000209	CcSEcCtD
Indomethacin—Dermatitis—Perindopril—coronary artery disease	8.51e-06	0.000209	CcSEcCtD
Indomethacin—Nausea—Telmisartan—coronary artery disease	8.5e-06	0.000209	CcSEcCtD
Indomethacin—Fatigue—Lisinopril—coronary artery disease	8.5e-06	0.000209	CcSEcCtD
Indomethacin—Headache—Perindopril—coronary artery disease	8.47e-06	0.000208	CcSEcCtD
Indomethacin—Urticaria—Timolol—coronary artery disease	8.44e-06	0.000207	CcSEcCtD
Indomethacin—Constipation—Lisinopril—coronary artery disease	8.43e-06	0.000207	CcSEcCtD
Indomethacin—Pain—Lisinopril—coronary artery disease	8.43e-06	0.000207	CcSEcCtD
Indomethacin—Abdominal pain—Timolol—coronary artery disease	8.4e-06	0.000206	CcSEcCtD
Indomethacin—Body temperature increased—Timolol—coronary artery disease	8.4e-06	0.000206	CcSEcCtD
Indomethacin—Dizziness—Losartan—coronary artery disease	8.38e-06	0.000206	CcSEcCtD
Indomethacin—Vomiting—Furosemide—coronary artery disease	8.35e-06	0.000205	CcSEcCtD
Indomethacin—Rash—Furosemide—coronary artery disease	8.29e-06	0.000203	CcSEcCtD
Indomethacin—Dermatitis—Furosemide—coronary artery disease	8.28e-06	0.000203	CcSEcCtD
Indomethacin—Nausea—Captopril—coronary artery disease	8.27e-06	0.000203	CcSEcCtD
Indomethacin—Headache—Furosemide—coronary artery disease	8.23e-06	0.000202	CcSEcCtD
Indomethacin—Feeling abnormal—Lisinopril—coronary artery disease	8.12e-06	0.000199	CcSEcCtD
Indomethacin—Gastrointestinal pain—Lisinopril—coronary artery disease	8.06e-06	0.000198	CcSEcCtD
Indomethacin—Vomiting—Losartan—coronary artery disease	8.06e-06	0.000198	CcSEcCtD
Indomethacin—Nausea—Perindopril—coronary artery disease	8.03e-06	0.000197	CcSEcCtD
Indomethacin—Hypersensitivity—Ramipril—coronary artery disease	8.01e-06	0.000196	CcSEcCtD
Indomethacin—Rash—Losartan—coronary artery disease	7.99e-06	0.000196	CcSEcCtD
Indomethacin—Dermatitis—Losartan—coronary artery disease	7.99e-06	0.000196	CcSEcCtD
Indomethacin—Headache—Losartan—coronary artery disease	7.94e-06	0.000195	CcSEcCtD
Indomethacin—Urticaria—Lisinopril—coronary artery disease	7.83e-06	0.000192	CcSEcCtD
Indomethacin—Hypersensitivity—Timolol—coronary artery disease	7.83e-06	0.000192	CcSEcCtD
Indomethacin—Nausea—Furosemide—coronary artery disease	7.81e-06	0.000191	CcSEcCtD
Indomethacin—Asthenia—Ramipril—coronary artery disease	7.8e-06	0.000191	CcSEcCtD
Indomethacin—Abdominal pain—Lisinopril—coronary artery disease	7.79e-06	0.000191	CcSEcCtD
Indomethacin—Body temperature increased—Lisinopril—coronary artery disease	7.79e-06	0.000191	CcSEcCtD
Indomethacin—Pruritus—Ramipril—coronary artery disease	7.69e-06	0.000189	CcSEcCtD
Indomethacin—Asthenia—Timolol—coronary artery disease	7.63e-06	0.000187	CcSEcCtD
Indomethacin—Nausea—Losartan—coronary artery disease	7.53e-06	0.000185	CcSEcCtD
Indomethacin—Pruritus—Timolol—coronary artery disease	7.52e-06	0.000184	CcSEcCtD
Indomethacin—Diarrhoea—Ramipril—coronary artery disease	7.44e-06	0.000182	CcSEcCtD
Indomethacin—Diarrhoea—Timolol—coronary artery disease	7.27e-06	0.000178	CcSEcCtD
Indomethacin—Hypersensitivity—Lisinopril—coronary artery disease	7.26e-06	0.000178	CcSEcCtD
Indomethacin—Dizziness—Ramipril—coronary artery disease	7.19e-06	0.000176	CcSEcCtD
Indomethacin—Asthenia—Lisinopril—coronary artery disease	7.07e-06	0.000174	CcSEcCtD
Indomethacin—Dizziness—Timolol—coronary artery disease	7.03e-06	0.000172	CcSEcCtD
Indomethacin—Pruritus—Lisinopril—coronary artery disease	6.98e-06	0.000171	CcSEcCtD
Indomethacin—Vomiting—Ramipril—coronary artery disease	6.91e-06	0.00017	CcSEcCtD
Indomethacin—Rash—Ramipril—coronary artery disease	6.85e-06	0.000168	CcSEcCtD
Indomethacin—Dermatitis—Ramipril—coronary artery disease	6.85e-06	0.000168	CcSEcCtD
Indomethacin—Headache—Ramipril—coronary artery disease	6.81e-06	0.000167	CcSEcCtD
Indomethacin—Vomiting—Timolol—coronary artery disease	6.76e-06	0.000166	CcSEcCtD
Indomethacin—Diarrhoea—Lisinopril—coronary artery disease	6.75e-06	0.000165	CcSEcCtD
Indomethacin—Rash—Timolol—coronary artery disease	6.7e-06	0.000164	CcSEcCtD
Indomethacin—Dermatitis—Timolol—coronary artery disease	6.69e-06	0.000164	CcSEcCtD
Indomethacin—Headache—Timolol—coronary artery disease	6.66e-06	0.000163	CcSEcCtD
Indomethacin—Dizziness—Lisinopril—coronary artery disease	6.52e-06	0.00016	CcSEcCtD
Indomethacin—Nausea—Ramipril—coronary artery disease	6.46e-06	0.000158	CcSEcCtD
Indomethacin—Nausea—Timolol—coronary artery disease	6.31e-06	0.000155	CcSEcCtD
Indomethacin—Vomiting—Lisinopril—coronary artery disease	6.27e-06	0.000154	CcSEcCtD
Indomethacin—Rash—Lisinopril—coronary artery disease	6.22e-06	0.000152	CcSEcCtD
Indomethacin—Dermatitis—Lisinopril—coronary artery disease	6.21e-06	0.000152	CcSEcCtD
Indomethacin—Headache—Lisinopril—coronary artery disease	6.18e-06	0.000152	CcSEcCtD
Indomethacin—Nausea—Lisinopril—coronary artery disease	5.86e-06	0.000144	CcSEcCtD
Indomethacin—AKR1C3—Disease—IL6—coronary artery disease	3.38e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAT—coronary artery disease	3.37e-07	1.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOC3—coronary artery disease	3.37e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGT—coronary artery disease	3.37e-07	1.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—coronary artery disease	3.36e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PSMB5—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PSMA6—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LDLR—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.35e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLCB1—coronary artery disease	3.32e-07	1.02e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.31e-07	1.02e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.31e-07	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—coronary artery disease	3.3e-07	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CTGF—coronary artery disease	3.27e-07	1.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOB—coronary artery disease	3.27e-07	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GCLC—coronary artery disease	3.27e-07	1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CETP—coronary artery disease	3.27e-07	1e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMB5—coronary artery disease	3.27e-07	1e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMA6—coronary artery disease	3.27e-07	1e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOA1—coronary artery disease	3.26e-07	1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.26e-07	1e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—coronary artery disease	3.25e-07	9.98e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMGCR—coronary artery disease	3.25e-07	9.97e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GOT2—coronary artery disease	3.25e-07	9.97e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SDC1—coronary artery disease	3.24e-07	9.94e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—coronary artery disease	3.23e-07	9.92e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—coronary artery disease	3.23e-07	9.91e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCA1—coronary artery disease	3.22e-07	9.9e-06	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—coronary artery disease	3.21e-07	9.86e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—coronary artery disease	3.2e-07	9.84e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CTGF—coronary artery disease	3.2e-07	9.82e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—coronary artery disease	3.2e-07	9.82e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—coronary artery disease	3.19e-07	9.81e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—coronary artery disease	3.19e-07	9.79e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—coronary artery disease	3.18e-07	9.78e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—coronary artery disease	3.18e-07	9.77e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—coronary artery disease	3.17e-07	9.74e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—coronary artery disease	3.17e-07	9.74e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMGCR—coronary artery disease	3.17e-07	9.73e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GOT2—coronary artery disease	3.17e-07	9.73e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—coronary artery disease	3.16e-07	9.7e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—coronary artery disease	3.14e-07	9.64e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—coronary artery disease	3.13e-07	9.61e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—LPL—coronary artery disease	3.13e-07	9.6e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.12e-07	9.59e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GGT1—coronary artery disease	3.12e-07	9.58e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GOT1—coronary artery disease	3.12e-07	9.58e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—coronary artery disease	3.12e-07	9.57e-06	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.11e-07	9.54e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—coronary artery disease	3.1e-07	9.51e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOA1—coronary artery disease	3.09e-07	9.5e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—coronary artery disease	3.08e-07	9.46e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—coronary artery disease	3.06e-07	9.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.06e-07	9.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.06e-07	9.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.05e-07	9.37e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—coronary artery disease	3.05e-07	9.36e-06	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—coronary artery disease	3.04e-07	9.32e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—coronary artery disease	3.03e-07	9.31e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—coronary artery disease	3.03e-07	9.31e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—coronary artery disease	3.01e-07	9.23e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CTGF—coronary artery disease	2.99e-07	9.17e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLCB1—coronary artery disease	2.98e-07	9.17e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—coronary artery disease	2.97e-07	9.13e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CD36—coronary artery disease	2.97e-07	9.12e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.96e-07	9.09e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GOT2—coronary artery disease	2.96e-07	9.09e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6ST—coronary artery disease	2.94e-07	9.02e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPP2CA—coronary artery disease	2.93e-07	9.01e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.93e-07	8.99e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—coronary artery disease	2.92e-07	8.98e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—coronary artery disease	2.92e-07	8.95e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—coronary artery disease	2.91e-07	8.95e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLCB1—coronary artery disease	2.91e-07	8.95e-06	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—coronary artery disease	2.91e-07	8.94e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—coronary artery disease	2.91e-07	8.92e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.89e-07	8.88e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—coronary artery disease	2.87e-07	8.83e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—coronary artery disease	2.83e-07	8.71e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ABCA1—coronary artery disease	2.82e-07	8.67e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—coronary artery disease	2.82e-07	8.67e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—coronary artery disease	2.82e-07	8.67e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—coronary artery disease	2.81e-07	8.64e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—coronary artery disease	2.8e-07	8.61e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GOT1—coronary artery disease	2.8e-07	8.6e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GGT1—coronary artery disease	2.8e-07	8.6e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—coronary artery disease	2.78e-07	8.54e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARGC1A—coronary artery disease	2.78e-07	8.53e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—coronary artery disease	2.77e-07	8.52e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—coronary artery disease	2.77e-07	8.52e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—coronary artery disease	2.77e-07	8.51e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—coronary artery disease	2.76e-07	8.49e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GGT1—coronary artery disease	2.73e-07	8.4e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GOT1—coronary artery disease	2.73e-07	8.4e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—coronary artery disease	2.73e-07	8.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.72e-07	8.36e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GSK3B—coronary artery disease	2.71e-07	8.32e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—coronary artery disease	2.7e-07	8.29e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREB1—coronary artery disease	2.69e-07	8.25e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—coronary artery disease	2.67e-07	8.21e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—coronary artery disease	2.67e-07	8.21e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—coronary artery disease	2.67e-07	8.21e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.67e-07	8.2e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOB—coronary artery disease	2.65e-07	8.13e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.64e-07	8.1e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6R—coronary artery disease	2.62e-07	8.05e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—coronary artery disease	2.62e-07	8.05e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—coronary artery disease	2.61e-07	8.02e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—coronary artery disease	2.59e-07	7.95e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—coronary artery disease	2.59e-07	7.95e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—coronary artery disease	2.58e-07	7.94e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—coronary artery disease	2.58e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GGT1—coronary artery disease	2.55e-07	7.85e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GOT1—coronary artery disease	2.55e-07	7.85e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—coronary artery disease	2.54e-07	7.81e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—coronary artery disease	2.54e-07	7.8e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—coronary artery disease	2.53e-07	7.77e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.52e-07	7.73e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.49e-07	7.66e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.48e-07	7.62e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.48e-07	7.62e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—coronary artery disease	2.48e-07	7.61e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—coronary artery disease	2.47e-07	7.59e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—coronary artery disease	2.47e-07	7.58e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—coronary artery disease	2.46e-07	7.54e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—coronary artery disease	2.45e-07	7.54e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—coronary artery disease	2.45e-07	7.52e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.43e-07	7.47e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—coronary artery disease	2.43e-07	7.46e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—coronary artery disease	2.42e-07	7.44e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD36—coronary artery disease	2.4e-07	7.38e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—coronary artery disease	2.39e-07	7.34e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOB—coronary artery disease	2.38e-07	7.3e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—coronary artery disease	2.38e-07	7.3e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPP2CA—coronary artery disease	2.37e-07	7.29e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—coronary artery disease	2.37e-07	7.27e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—coronary artery disease	2.34e-07	7.2e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOB—coronary artery disease	2.32e-07	7.13e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.31e-07	7.1e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—coronary artery disease	2.31e-07	7.09e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.29e-07	7.05e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—coronary artery disease	2.28e-07	7.01e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JAK2—coronary artery disease	2.28e-07	7e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—coronary artery disease	2.28e-07	6.99e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.27e-07	6.98e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—coronary artery disease	2.27e-07	6.97e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—coronary artery disease	2.26e-07	6.95e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—coronary artery disease	2.26e-07	6.95e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.26e-07	6.95e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—coronary artery disease	2.26e-07	6.94e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—coronary artery disease	2.26e-07	6.93e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—coronary artery disease	2.25e-07	6.91e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—coronary artery disease	2.23e-07	6.86e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—coronary artery disease	2.22e-07	6.8e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—coronary artery disease	2.21e-07	6.8e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—coronary artery disease	2.2e-07	6.77e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—coronary artery disease	2.18e-07	6.7e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOB—coronary artery disease	2.17e-07	6.66e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—coronary artery disease	2.16e-07	6.64e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—coronary artery disease	2.16e-07	6.64e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD36—coronary artery disease	2.16e-07	6.62e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.13e-07	6.54e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—coronary artery disease	2.12e-07	6.51e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.11e-07	6.48e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—coronary artery disease	2.11e-07	6.47e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD36—coronary artery disease	2.1e-07	6.46e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—coronary artery disease	2.1e-07	6.45e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—coronary artery disease	2.1e-07	6.45e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—coronary artery disease	2.1e-07	6.43e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—coronary artery disease	2.09e-07	6.41e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.08e-07	6.38e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—coronary artery disease	2.07e-07	6.36e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—coronary artery disease	2.05e-07	6.3e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.04e-07	6.28e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—coronary artery disease	2.02e-07	6.2e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.01e-07	6.16e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—coronary artery disease	1.99e-07	6.13e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—coronary artery disease	1.99e-07	6.1e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD36—coronary artery disease	1.97e-07	6.04e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—coronary artery disease	1.96e-07	6.03e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—coronary artery disease	1.96e-07	6.03e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.94e-07	5.96e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—coronary artery disease	1.94e-07	5.96e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—coronary artery disease	1.9e-07	5.84e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—coronary artery disease	1.9e-07	5.82e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—coronary artery disease	1.88e-07	5.78e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—coronary artery disease	1.87e-07	5.73e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.86e-07	5.72e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—coronary artery disease	1.86e-07	5.7e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—coronary artery disease	1.85e-07	5.67e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—coronary artery disease	1.84e-07	5.64e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	1.83e-07	5.62e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—coronary artery disease	1.82e-07	5.59e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.8e-07	5.53e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—coronary artery disease	1.8e-07	5.53e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—coronary artery disease	1.77e-07	5.44e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—coronary artery disease	1.74e-07	5.34e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—coronary artery disease	1.73e-07	5.33e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—coronary artery disease	1.72e-07	5.29e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—coronary artery disease	1.72e-07	5.27e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—coronary artery disease	1.72e-07	5.27e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—coronary artery disease	1.71e-07	5.27e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—coronary artery disease	1.71e-07	5.24e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—coronary artery disease	1.71e-07	5.24e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—coronary artery disease	1.66e-07	5.09e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—coronary artery disease	1.65e-07	5.05e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.64e-07	5.04e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—coronary artery disease	1.63e-07	5.02e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—coronary artery disease	1.62e-07	4.98e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—coronary artery disease	1.62e-07	4.97e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—coronary artery disease	1.61e-07	4.93e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—coronary artery disease	1.6e-07	4.9e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—coronary artery disease	1.59e-07	4.88e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	1.56e-07	4.8e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—coronary artery disease	1.55e-07	4.76e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—coronary artery disease	1.52e-07	4.67e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—coronary artery disease	1.51e-07	4.64e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—coronary artery disease	1.49e-07	4.59e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—coronary artery disease	1.49e-07	4.58e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—coronary artery disease	1.49e-07	4.58e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—coronary artery disease	1.45e-07	4.47e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—coronary artery disease	1.45e-07	4.46e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—coronary artery disease	1.43e-07	4.38e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—coronary artery disease	1.39e-07	4.28e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—coronary artery disease	1.39e-07	4.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—coronary artery disease	1.39e-07	4.27e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—coronary artery disease	1.39e-07	4.27e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—coronary artery disease	1.36e-07	4.17e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—coronary artery disease	1.34e-07	4.13e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—coronary artery disease	1.32e-07	4.05e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.3e-07	4e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—coronary artery disease	1.3e-07	3.99e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—coronary artery disease	1.28e-07	3.92e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—coronary artery disease	1.27e-07	3.91e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.19e-07	3.65e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—coronary artery disease	1.17e-07	3.59e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—coronary artery disease	1.14e-07	3.49e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—coronary artery disease	1.1e-07	3.39e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—coronary artery disease	1.08e-07	3.31e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—coronary artery disease	9.02e-08	2.77e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—coronary artery disease	8.93e-08	2.74e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—coronary artery disease	8.02e-08	2.46e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.83e-08	2.4e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.31e-08	2.25e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—coronary artery disease	7.3e-08	2.24e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—coronary artery disease	6.55e-08	2.01e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—coronary artery disease	6.39e-08	1.96e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—coronary artery disease	5.97e-08	1.83e-06	CbGpPWpGaD
